Ibrahim Qaqish, MD
Nephrology · Phoenix, AZNPI 1740462431
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.0% of the total across 157 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 29 manufacturers, the largest accounting for just 16.4% — the pattern of someone who eats at a lot of different presentations.
Across 157 payments — averaging $42.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$1K
- Mallinckrodt Hospital Products Inc.$658
- Amgen$527
- Otsuka America Pharmaceutical, Inc.$520
- Travere Therapeutics, Inc.$461
- Novo Nordisk$417
- plus $3K from 23 others
What the payments were for
- Food & beverage$6,61299%
- Education$661%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca(2 entities) | 21 | $1,095 |
| Mallinckrodt Hospital Products Inc. | 10 | $658 |
| Amgen(2 entities) | 14 | $527 |
| Otsuka America Pharmaceutical, Inc. | 17 | $520 |
| Travere Therapeutics, Inc. | 5 | $461 |
| Novo Nordisk | 6 | $417 |
| Bayer | 14 | $358 |
| Takeda Pharmaceuticals U.S.A., Inc. | 12 | $291 |
| Novartis | 5 | $218 |
| Fresenius USA Marketing, Inc. | 2 | $210 |
| Merck | 11 | $209 |
| Veloxis Pharmaceuticals, Inc. | 7 | $207 |
| Abbott | 1 | $185 |
| Nxstage Medical, Inc. | 2 | $158 |
| Akebia Therapeutics Inc | 3 | $156 |
| Vifor Pharma, Inc. | 4 | $139 |
| Mallinckrodt Enterprises LLC | 2 | $137 |
| Calliditas Therapeutics US Inc. | 3 | $128 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $121 |
| Lilly USA, LLC | 1 | $119 |
| GSK | 2 | $104 |
| Aurinia Pharma U.S., Inc. | 4 | $85 |
| OPKO Pharmaceuticals, LLC | 3 | $47 |
| Johnson & Johnson | 2 | $35 |
| Boehringer Ingelheim | 1 | $23 |
| ANI Pharmaceuticals, Inc. | 1 | $20 |
| Apellis Pharmaceuticals, Inc. | 1 | $19 |
| Genentech USA, Inc. | 1 | $19 |
| AbbVie | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,678 in reported general payments places this provider in the 85th percentile of 259 nephrology providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 20 | $14,071 |
| Fluconazole | 302 | $11,903 |
| Valganciclovir Hcl | 63 | $9,157 |
| Cinacalcet Hcl | 43 | $3,144 |
| Mycophenolate Mofetil | 20 | $2,383 |
| Tacrolimus | 18 | $2,327 |
| Nano 2nd Gen Pen NeedlePen Needle, Diabetic | 20 | $1,230 |
| Prednisone | 190 | $968 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 107 | $892 |
| Calcitriol | 19 | $857 |
| Nifedipine ErNifedipine | 57 | $784 |
| Tamsulosin Hcl | 67 | $761 |
| Carvedilol | 90 | $584 |
| Bumetanide | 11 | $583 |
| Famotidine | 67 | $556 |
Paid to pharmacies, not to this prescriber.
Other nephrology in Phoenix
- Samer Bani HaniPhoenix$54K
- Leslie ThomasPhoenix$22K
- Alexander NimriPhoenix$21K
- Edgardo LaurelPhoenix$15K
- Sharareh SaadatPhoenix$15K
- Amar BistaPhoenix$12K
- Maher MousaPhoenix$9K
- Paul SacksPhoenix$8K
- William WeissPhoenix$8K
- Esmat MustafaPhoenix$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.